Killian Meara

Children with type 1 diabetes who watched educational videos and played games had improved glycemic control and quality of life.

Rebecca Lahrman, PharmD, MS, BCACP discusses her time as a preceptor and what she learned from the experience.

Axsome Therapeutics expects the therapy to be commercially available in the United States in approximately 4 months.

The decision makes the selective NaV1.8 pain signal inhibitor the first new class of medicine to treat acute pain in over 20 years.

Jennifer Bacci, PharmD, MPH, discusses ways to improve current issues impacting community pharmacy.

A recent systematic review and meta-analysis found that almost half of all patients with type 2 diabetes were deficient in multiple micronutrients.

Natalie DiPietro Mager, PharmD, PhD, discusses the role of community pharmacy in maternal health.

A supratherapeutic dose of 1000 ug cebranopadol was significantly less likeable compared to 40 mg oxycodone when crushed and taken intranasally.

A discussion with Natalie DiPietro Mager, PharmD, PhD, on how community pharmacists can improve access to contraceptive services.

Natalie DiPietro Mager, PharmD, PhD, professor of pharmacy practice at Ohio Northern University, provides best tips and practices for providing maternity care.

Heather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM discuss challenges pharmacists may face when implementing CGM services and how they can help raise awareness.

A discussion with Natalie DiPietro Mager, PharmD, PhD, professor of pharmacy practice at Ohio Northern University.

Cebranopadol is a first-in-class investigational therapy that targets the nociceptin/orphanin FQ receptor and the µ-opioid receptor.

The approval makes Johnson and Johnson’s esketamine nasal spray the first and only monotherapy for the treatment of major depressive disorder in adult patients.

A conversation with Antonia Biggs, PhD, professor and acting director of the Advancing New Standards in Reproductive Health Program at the University of California, San Francisco.

A poll conducted by the Global Healthy Living Foundation found 11% of respondents with chronic conditions do not plan to get vaccinated for flu, COVID-19 or RSV.

Support for and personal interest in expanded access to advance provision and over-the-counter medication abortion has increased significantly since the constitutional right to abortion was overturned by the Supreme Court.

A conversation with Jennifer Bacci, PharmD, MPH, endowed associate professor of Innovative Pharmacy Practice at the University of Washington School of Pharmacy.

The therapy is the first and only prefilled testosterone cypionate injection approved by the FDA.

A conversation with David Nau, PhD, professor of social and administrative pharmacy, and director of assessment at Ohio Northern University.

RGT-075 from Regor Therapeutics demonstrated a statistically significant 5% placebo-adjusted weight loss in adult patients with obesity or overweight.

A conversation with Heather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM.

A combination of ibuprofen and acetaminophen was found to be superior to hydrocodone and acetaminophen in managing pain after impacted mandibular third-molar extraction surgery.

Heather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM, discuss a recent study that examined how wearing a continuous glucose monitor impacts student pharmacists.

Investigators of a recent study said targeted interventions are needed to reduce the global burden, particularly in developing countries.

Henry Ukachukwu Michael, PhD, discusses the importance of optimizing medication utilization in patients with long COVID.

MET-097i from Metsera demonstrated substantial reductions in mean body weight in patients with obesity or overweight who did not have type 2 diabetes.

David Nau, PhD, discusses how more graduating pharmacy students say they would choose pharmacy again if starting college over.

Rebecca Lahrman, PharmD, MS, BCACP, discusses her experience taking medical students for rotations in a community pharmacy.

A study found that of 110 patients with long COVID, over half reported decreased QOL due to pain, discomfort, anxiety, or depression.